[1]
F. Z. Muttaqin, H. Ramadhanty, H. N. Muhammad, and I. Musfiroh, “Inhibiting Adenosine A2A Receptors as a Treatment for Parkinson’s Disease”, sjp, vol. 1, no. 1, pp. 1-5, May 2022.